Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer

Akihiro Yamamura1, Koh Miura, Hideaki Karasawa

  • 1Department of Surgery, Tohoku University, Graduate School of Medicine, Sendai, Japan; Department of Pathology, Tohoku University, Graduate School of Medicine, Sendai, Japan.

Insights

N-myc downstream regulated gene 2 (NDRG2) is downregulated in pancreatic cancer, correlating with poor prognosis. Histone modification, not DNA methylation, appears to silence NDRG2, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Pancreatic cancer is a lethal disease with poorly understood molecular mechanisms.
  • N-myc downstream regulated gene 2 (NDRG2) is a potential tumor suppressor frequently downregulated in pancreatic cancer.
  • Limited data exists on NDRG2 expression in resected pancreatic cancer tissues.

Purpose of the Study:

  • To investigate the association between NDRG2 expression and prognosis in pancreatic cancer.
  • To explore the role of epigenetic mechanisms, specifically DNA methylation and histone modification, in NDRG2 regulation.
  • To determine if NDRG2 expression is an independent prognostic factor.

Main Methods:

  • Immunohistochemistry was used to assess NDRG2 expression in 69 surgically resected pancreatic cancer specimens.
  • Cell lines were treated with trichostatin A (histone deacetylase inhibitor) and 5-aza-2' deoxycytidine (DNA demethylating agent).
  • Methylation-specific PCR was performed to detect hypermethylation in cell lines and tissues.

Main Results:

  • NDRG2-negative staining was significantly associated with poor prognosis in pancreatic cancer patients (P=0.038).
  • Trichostatin A upregulated NDRG2 expression in low-expressing cell lines, while 5-aza-2' deoxycytidine had no significant effect.
  • No hypermethylation of NDRG2 was detected in pancreatic cancer cell lines or specimens.

Conclusions:

  • NDRG2 functions as a tumor suppressor gene in pancreatic carcinogenesis.
  • Epigenetic silencing of NDRG2 likely involves histone modifications rather than DNA methylation.
  • NDRG2 expression serves as an independent prognostic factor for pancreatic cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K